Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) EBT Margin (2018 - 2025)

AVITA Medical (RCEL) has disclosed EBT Margin for 7 consecutive years, with 12.65% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 29084.0% year-over-year to 12.65%, compared with a TTM value of 22.83% through Dec 2025, down 2281.0%, and an annual FY2025 reading of 68.53%, down 6851.0% over the prior year.
  • EBT Margin was 12.65% for Q4 2025 at AVITA Medical, up from 15.68% in the prior quarter.
  • Across five years, EBT Margin topped out at 309.37% in Q4 2022 and bottomed at 167.76% in Q1 2024.
  • Average EBT Margin over 4 years is 9.99%, with a median of 69.29% recorded in 2023.
  • Peak annual rise in EBT Margin hit 9295bps in 2025, while the deepest fall reached -29084bps in 2025.
  • Year by year, EBT Margin stood at 309.37% in 2022, then dropped by -14bps to 265.15% in 2023, then rose by 5bps to 278.19% in 2024, then crashed by -105bps to 12.65% in 2025.
  • Business Quant data shows EBT Margin for RCEL at 12.65% in Q4 2025, 15.68% in Q3 2025, and 54.41% in Q2 2025.